Peri-implantitis Market Size To Reach $1.75 Billion By 2030

Peri-implantitis Market Growth & Trends

The global peri-implantitis market size is expected to reach USD 1.75 billion by 2030, expanding at a CAGR of 9.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Peri-implantitis is a site-specific destructive inflammatory disease affecting soft and hard tissues around osseointegrated implants, causing a decrease in bone volume and formation of peri-implant pockets. The success rate of dental implants was reported to be 92%–98% over a period of 10 years. Yet, factors like increasing patients with a history of periodontitis, the advent of technological advancement pertaining to efficient treatment of peri-implantitis, and a rise in the patient population prone to smoking and diabetes are fueling the market growth.

The prevalence of peri-implant complication is expected to be on the rise with the increased number of implants being placed around the globe. According to NCBI, in the U.S. from 1999 to 2017, per year 14.0% increase in implant prevalence was recorded. Annually there are about 2,60,000 implants placed in the U.K., which indicates the growing demand for dental implants. As implants are becoming a common treatment, associated disease prevalence including peri-implant mucositis and peri-implantitis shows a positive correlation. Moreover, according to the CDC, 47.2% of adults aged 30 years in the U.S suffered from some form of periodontal disease in 2019. The condition is more common in men than women as they are more prone to smoking and health conditions like diabetes. Advancements like laser debridement, guided bone regeneration (GBR), and diagnostic genetic biomarker technique are expected to boost peri-implantitis treatment market growth.

 Request a free sample copy or view report summary: Peri-implantitis Market Report

Peri-implantitis Market Report Highlights

• The surgical segment dominated the market in 2024 due to the fact that surgical debridement procedures are efficient and are considered as the most effective technique to treat peri-implantitis

• Laser debridement non-surgical technique is anticipated to witness the highest growth over the forecast period as it has improved clinical outcomes are efficient due to selective calculus removal

• Europe dominated the market in 2024 owing to the rising technological advancements for peri-implantitis treatment

• In the Asia Pacific, the market is expected to witness the highest CAGR over the forecast period owing to the growing geriatric patient population, rising awareness about dental implants and associated disease, and rapid technological advancements.

Peri-implantitis Market Segmentation

Grand View Research has segmented the global peri-implantitis market report based on method type, and region:

Peri-implantitis Method Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Surgical

  • Bone Regeneration

  • Open Flap Debridement

  • Implantoplasty

• Non-surgical

  • Mechanical Debridement

  • Laser Debridement

  • Antibiotics

  • Others

Peri-implantitis Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

  • U.S.    

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Peri-implantitis Market

• Pfizer Inc.

• Cadila Pharmaceuticals

• GaronitPharma

• Basic Pharma Life Science Pvt Ltd.

• Prachi Pharmaceuticals Private Limited.

• Geistlich Pharma India Pvt. Ltd.

• Healthy Life Pharma Private Limited.

• Zimmer Biomet.

• Institut Straumann AG

• Dentsply Sirona